Eli Lilly and Company-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2016

  1. NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation

    Scientific Reports, Vol. 6